Silvia Nicolini
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori(IT)
Publications by Year
Research Areas
Neuroendocrine Tumor Research Advances, Lung Cancer Research Studies, Neuroblastoma Research and Treatments, Radiopharmaceutical Chemistry and Applications, Prostate Cancer Treatment and Research
Most-Cited Works
- → PET/CT imaging in different types of lung cancer: An overview(2011)189 cited
- → Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors(2015)141 cited
- → Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATE(2016)118 cited
- → Peptide receptor radionuclide therapy with 177Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and 18F-FDG PET(2015)100 cited
- → Investigation of receptor radionuclide therapy with 177Lu-DOTATATE in patients with GEP-NEN and a high Ki-67 proliferation index(2018)78 cited
- → Feasibility and utility of re-treatment with 177Lu-DOTATATE in GEP-NENs relapsed after treatment with 90Y-DOTATOC(2015)68 cited
- → 18F-FDG PET/CT impact on testicular tumours clinical management(2013)61 cited
- → Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumors(2021)58 cited
- → Dosimetry and safety of 177Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patients(2020)57 cited
- → Peptide receptor radionuclide therapy in patients with metastatic progressive pheochromocytoma and paraganglioma: long-term toxicity, efficacy and prognostic biomarker data of phase II clinical trials(2021)56 cited